Exchange Traded Concepts’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-131,830	Closed	-$104K	–	1437
2025 Q1	$104K	Buy	131,830 +89,541	+212%	+$110K	﹤0.01%	1149
2024 Q4	$69.8K	Hold	42,289	–	–	﹤0.01%	1195
2024 Q3	$148K	Buy	42,289 +12,230	+41%	+$47.6K	﹤0.01%	1072
2024 Q2	$98.6K	Sell	30,059 -9,351	-24%	-$40.9K	﹤0.01%	940
2024 Q1	$289K	Sell	39,410 -24,315	-38%	-$151K	0.01%	812
2023 Q4	$238K	Buy	63,725 +16,159	+34%	+$38.1K	0.01%	773
2023 Q3	$101K	Buy	47,566 +21,955	+86%	+$72.7K	﹤0.01%	891
2023 Q2	$122K	Sell	25,611 -196,990	-88%	-$1.09M	﹤0.01%	905
2023 Q1	$1.27M	Buy	222,601 +181,304	+439%	+$1.09M	0.03%	289
2022 Q4	$417K	Buy	41,297 +10,186	+33%	+$191K	0.01%	556
2022 Q3	$697K	Sell	31,111 -5,739	-16%	-$166K	0.02%	322
2022 Q2	$913K	Buy	36,850 +2,586	+8%	+$71.4K	0.03%	306
2022 Q1	$1.33M	Buy	34,264 +4,465	+15%	+$173K	0.03%	283
2021 Q4	$1.74M	Buy	29,799 +5,201	+21%	+$295K	0.03%	256
2021 Q3	$1.46M	Buy	+24,598	New	+$1.93M	0.04%	266
2021 Q2	–	Sell	-2,039	Closed	-$168K	–	1147
2021 Q1	$168K	Sell	2,039 -9,103	-82%	-$872K	0.01%	676
2020 Q4	$1.01M	Sell	11,142 -6,818	-38%	-$423K	0.05%	225
2020 Q3	$718K	Buy	+17,960	New	+$627K	0.04%	211